No. J9062 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What NDCs are billed under J9062?

CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 4 NDCs under J9062, for Rybrevant Faspro. The table on this page shows each one with its billing units per package.

What is the Medicare payment limit for J9062?

$40.492 per 5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J9062 J-Code: Rybrevant Faspro

In short

J9062 is the HCPCS Level II code for injection, amivantamab 5 mg and hyaluronidase-lpuj. CMS assigns NDCs for Rybrevant Faspro to it. The Medicare Part B payment limit is $40.492 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file

HCPCS codeJ9062

Billing unitSee descriptor

Descriptor: Injection, amivantamab 5 mg and hyaluronidase-lpuj
Short descriptor: Inj amivantamab 5mg hyaluron
Code set: HCPCS Level II, maintained by CMS
Effective: Jul 1, 2026

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$40.492

Per5 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

HCPCS units

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the units to build the claim line.

NDCs billed under J9062

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 4 NDCs to J9062 for Rybrevant Faspro. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J9062 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Rybrevant Faspro	57894-0510-01	Janssen Biotech, Inc.	10	320
Rybrevant Faspro	57894-0514-01	Janssen Biotech, Inc.	14	448
Rybrevant Faspro	57894-0515-01	Janssen Biotech, Inc.	15	480
Rybrevant Faspro	57894-0522-01	Janssen Biotech, Inc.	22	704

J9062: common questions

Is J9062 a CPT code?: No. J9062 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J9062?: CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 4 NDCs under J9062, for Rybrevant Faspro. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J9062?: $40.492 per 5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

J9062 — Injection, amivantamab 5 mg and hyaluronidase-lpuj